Drug profile · INN
pafolacianine sodium
CYTALUX
pafolacianine sodium (CYTALUX) is a diagnostic. Route of administration: intravenous. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — pafolacianine sodium
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
pafolacianine sodium (CYTALUX) is a diagnostic. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN pafolacianine sodium
Brand CYTALUX
Mechanism Diagnostic
Route INTRAVENOUS
Formulation SOLUTION
Mechanism of action
Diagnostic
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is pafolacianine sodium?
pafolacianine sodium (CYTALUX) is a diagnostic. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for pafolacianine sodium?
CYTALUX is a marketed brand name for pafolacianine sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pafolacianine sodium?
pafolacianine sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.